Vimarsana
Biggest News Aggregation in the World

Page 3 - Advancing Care News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advancing Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advancing Care Today - Breaking & Trending Today

UK HealthCare hosting 2 nationally esteemed guests for 60th anniversary symposium - Vimarsana News

UK HealthCare hosting 2 nationally esteemed guests for 60th anniversary symposium

The 60th Anniversary Symposium: Advancing Care in Kentucky and Beyond will feature Robert Califf, M.D., commissioner of food and drugs for the Food and Drug Administration, and Daniel Kraft, M.D., physician-scientist, innovator and founder/chair of Exponential Medicine.

Source: uky.edu
ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes using M1Pram in a pos - Vimarsana News

ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes using M1Pram in a pos

A weight loss of 5.5kg measured at 16 weeks of treatment in people with type 1 diabetes and a body mass index greater than 30kg/m2Glycemic control efficacy comparable to that obtained with the commercial reference insulin Humalog® (Eli Lilly)These results were presented at the 58th European Association for the Study...

Patient-Centered Care Takes Center Stage in New Report from AHRQ's Digital Healthcare Research Program - Vimarsana News

Patient-Centered Care Takes Center Stage in New Report from AHRQ's Digital Healthcare Research Program

In the Digital Healthcare Research program’s newly released 2021 annual report, Improving Healthcare Through AHRQ’s Digital Healthcare Research, we highlight nearly 50 completed and ongoing projects that speak to digital healthcare technology’s growing promise for improving patient care.

Source: ahrq.gov
Mirati Therapeutics to Present New Research at the 2022 ASCO Annual Meeting Showcasing Clinical Advances of Treating KRASG12C-Mutated Lung Cancer with Investigational Adagrasib - Vimarsana News

Mirati Therapeutics to Present New Research at the 2022 ASCO Annual Meeting Showcasing Clinical Advances of Treating KRASG12C-Mutated Lung Cancer with Investigational Adagrasib

/PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX), a clinical-stage targeted oncology company today announced the presentation of new clinical research...

Mirati Therapeutics to Present New Research at the 2022 ASCO Annual Meeting Showcasing Clinical Advances of Treating KRASG12C-Mutated Lung Cancer with Investigational Adagrasib - Vimarsana News

Mirati Therapeutics to Present New Research at the 2022 ASCO Annual Meeting Showcasing Clinical Advances of Treating KRASG12C-Mutated Lung Cancer with Investigational Adagrasib

/PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX), a clinical-stage targeted oncology company today announced the presentation of new clinical research...